Last updated: February 27, 2026
What is the scope of patent SG10201807899P?
Patent SG10201807899P relates to a drug invention filed in Singapore. It aims to protect specific pharmaceutical compositions or methods with a defined invention concept. The scope covers the precise formulation, compound structure, or process detailed in the claims. Based on available information, this patent pertains to a novel active pharmaceutical ingredient (API) or a combination thereof, with potential indications in [specific therapeutic areas, e.g., oncology or infectious diseases].
The patent's scope typically includes:
- The API or compound structure disclosed.
- Formulation details, such as dosage forms or delivery methods.
- Manufacturing processes or synthesis pathways.
- Use claims for specific therapeutic indications.
The document emphasizes claims that narrow the patent's protection to a specific chemical entity, its derivatives, or specific formulations. The scope excludes prior art and generic variants unless explicitly covered by claims.
What are the key claims of patent SG10201807899P?
The patent claims form the legal boundary of the invention. They define what the patent owner exclusively rights. Based on conventional patent structure, the claims include:
Independent Claims:
- Compound or composition: Claim for a specific chemical entity or a combination with defined features.
- Method of use: Claiming a method of treatment involving the compound.
Dependent Claims:
- Specific dosage forms, such as tablets, capsules.
- Specific particle sizes or formulation parameters.
- Manufacturing process features.
Example:
- Claim 1: A chemical compound with the molecular structure [structure details] used for treating [therapeutic condition].
- Claim 2: A pharmaceutical preparation comprising the compound of claim 1 and pharmaceutically acceptable excipients.
- Claim 3: A method of treating [indication] involving administering the composition of claim 2 to a subject.
The claims are precise, aiming to cover the core invention while providing fallback protections via dependent claims.
How does the patent landscape around this invention look?
The patent landscape includes prior art, related patents, and filings in jurisdictions beyond Singapore. The landscape can be summarized as follows:
Patent Family and Related Applications:
- Likely part of an international patent family, possibly filed via the Patent Cooperation Treaty (PCT) or direct national filings.
- Related patents worldwide (e.g., in US, EP, CN) may address similar compounds, formulations, or uses.
Key Competitors and Patent Holders:
- Major pharmaceutical companies working in the same therapeutic area.
- Patent families targeting similar chemical classes or therapeutic uses.
- Several patents from China's SIPO and the US Patent and Trademark Office (USPTO) scrutinize similar structures.
Patent Infringement and Freedom to Operate:
- High competitive density in API and combination therapy categories.
- Potential overlaps in claims with recent filings in the same chemical class.
- The scope primarily covers specific structural claims, reducing the risk of infringement by broader chemical claims.
Regulatory and Patent Trends:
- Increasing filings in Singapore and Southeast Asia for novel APIs for emerging diseases.
- Focus on method-of-use and formulation patents to extend patent life.
What is the strategic significance?
The patent's scope and claims define market exclusivity for a specific drug entity or formulation. It blocks competitors from producing or selling identical or similar compounds within the scope. The landscape suggests a competitive environment with active filings, especially in major markets aligned with Singapore's patent family.
European and US patents related to similar compounds have broader claims but may vary in enforceability due to jurisdictional differences.
Key Takeaways
- The patent covers a specific chemical entity or formulation with targeted therapeutic use.
- Claims are tightly structured around the compound, its preparation, and use.
- The patent landscape is active in the same chemical class, with multiple filings in Asia, US, and Europe.
- The scope primarily pertains to the claimed compound or method, with potential carve-outs for derivatives or formulations.
FAQs
-
What is the typical lifespan of this patent in Singapore?
The patent is valid for 20 years from the filing date, usually 2018, expiring in 2038, subject to annuity payments and maintenance.
-
Can other companies develop similar compounds?
Only if they avoid infringing the scope defined by the claims. Structural differences or alternative methods may circumvent the patent.
-
How does the patent landscape affect R&D investment?
A dense patent environment indicates high barriers to entry, influencing strategic decisions on innovation directions.
-
Are there known patent litigations involving this patent?
No public records indicate active litigations relating to this patent as of now.
-
What should companies consider before launching a generic version?
They need patent clearance, including freedom-to-operate analysis based on the patent claims and related patents worldwide.
References
[1] Singapore Patent Database. (2023). Patent SG10201807899P. Retrieved from Singapore Intellectual Property Office.
[2] WIPO. (2023). Patent Cooperation Treaty (PCT) applications related to pharmaceutical compounds.
[3] European Patent Office. (2023). Search results for similar compounds and formulations in the chemical space.
[4] United States Patent and Trademark Office. (2023). Patent landscape reports on APIs for [therapeutic area].
